摘要 |
The present invention relates to a chemical compound of formula (I) as a neutral or acidic salt thereof where the counter ions are Li<+>, Na<+>, K<+>, Mg<2+>, Ca<2+>, NH4<+> or another pharmacologically acceptable positively charged inorganic or organic ion or any combination thereof and a pharmaceutical composition comprising as a pharmaceutically active ingredient at least one compound of formula (I). |